By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ThromboGenics NV 

Gaston Geenslaan 1

Heverlee    B-3001  Belgium
Phone: 32-0-16-751310 Fax: 32-0-16-751311


SEARCH JOBS








Company News
ThromboGenics NV (TBGNF) Business Update – Q3 2016 10/20/2016 11:48:46 AM
Latest ThromboGenics NV (TBGNF)' Clinical Data To Be Presented At American Academy of Ophthalmology (AAO) Meeting In Chicago 10/12/2016 9:38:16 AM
ThromboGenics NV (TBGNF) Presenting New Ophthalmic Research Data 9/7/2016 3:15:03 PM
ThromboGenics NV (TBGNF) Presenting New Ophthalmic Research Data At 16th EURETINA Congress In Copenhagen 9/7/2016 11:52:49 AM
ThromboGenics NV (TBGNF) Business Update – H1 2016 8/25/2016 10:14:40 AM
ThromboGenics NV (TBGNF) 2-Year OASIS Study Results Published In Ophthalmology, Journal Of The American Academy Of Ophthalmology (AAO) 8/8/2016 7:59:34 AM
ThromboGenics NV (TBGNF) Presenting Ocriplasmin Research Findings At Upcoming ASRS 2016 Annual Scientific Meeting In San Francisco 8/3/2016 10:38:01 AM
ThromboGenics NV (TBGNF) Receives US FDA Approval For New 'Already-Diluted' Formulation Of JETREA 6/8/2016 10:11:31 AM
ThromboGenics NV (TBGNF) Business Update - Q1 2016 5/13/2016 9:51:26 AM
ThromboGenics NV (TBGNF) Release: New Ocriplasmin Research Findings Presented At Upcoming Association for Research in Vision & Ophthalmology 2016 Annual Meeting In Seattle 4/27/2016 8:37:34 AM
123456789
//-->